Ruxandra Chira, Jens Fangmeyer, Ioan O. Neaga, Valentin Zaharia, Uwe Karst, Ede Bodoki, Radu Oprean. Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2021, 11(5): 661-666. doi: 10.1016/j.jpha.2021.03.011
Citation:
Ruxandra Chira, Jens Fangmeyer, Ioan O. Neaga, Valentin Zaharia, Uwe Karst, Ede Bodoki, Radu Oprean. Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2021, 11(5): 661-666. doi: 10.1016/j.jpha.2021.03.011
Ruxandra Chira, Jens Fangmeyer, Ioan O. Neaga, Valentin Zaharia, Uwe Karst, Ede Bodoki, Radu Oprean. Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2021, 11(5): 661-666. doi: 10.1016/j.jpha.2021.03.011
Citation:
Ruxandra Chira, Jens Fangmeyer, Ioan O. Neaga, Valentin Zaharia, Uwe Karst, Ede Bodoki, Radu Oprean. Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2021, 11(5): 661-666. doi: 10.1016/j.jpha.2021.03.011
1.Analytical Chemistry Department, "luliu Hatieganu" University ofMedicine and Pharmacy, 400349, Cluj-Napoca, Romania;
2.University of Münster, Institute of Inorganic and AnalyticalChemistry, 48149, Münster, Germany;
3.Organic Chemistry Department, "luliu Hatieganu" University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
Funds:
The authors gratefully acknowledged the financial support for part of this work by the German Research Foundation (DFG, Grant No.: KA 1093/7-2, Bonn, Germany) as well as Iuliu Hațieganu University (Internal Grant No.: 5200/19/01.03.2017) and a grant of the Romanian Ministry of Education and Research, CCCDI-UEFISCDI (Project No.: PN–III–P2-2.1-PED-2019-5474) within PNCDI III.
Considering the frequent use of netupitant in polytherapy, the elucidation of its oxidative metabolization pattern is of major importance. However, there is a lack of published research on the redox behavior of this novel neurokinin-1 receptor antagonist. Therefore, this study was performed to simulate the intensive hepatic biotransformation of netupitant using an electrochemically driven method. Most of the known enzyme-mediated reactions occurring in the liver (i.e., N-dealkylation, hydroxylation, and N-oxidation) were successfully mimicked by the electrolytic cell using a boron-doped diamond working electrode. The products were separated by reversed-phase high-performance liquid chromatography and identified by high-resolution mass spectrometry. Aside from its ability to pinpoint formerly unknown metabolites that could be responsible for the known side effects of netupitant or connected with any new perspective concerning future therapeutic indications, this electrochemical process also represents a facile alternative for the synthesis of oxidation products for further in vitro and in vivo studies.